Aim and Scope
The Journal of Biomedical Frontiers and Molecular Medicine (JBFMM) is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research that advances biomedical sciences and molecular medicine. The journal aims to serve as a multidisciplinary platform for scientists, clinicians, healthcare professionals, and translational researchers to share innovative discoveries that improve the understanding, diagnosis, prevention, and treatment of human diseases. JBFMM emphasizes research that integrates molecular insights with clinical applications, accelerating the translation of scientific breakthroughs into improved healthcare outcomes.
Expanded Scope:
Molecular Medicine & Disease Mechanisms: Research investigating the molecular and cellular basis of human diseases, including genetic, epigenetic, metabolic, and signaling pathways that contribute to disease onset, progression, and therapeutic response.
Biomedical Sciences & Experimental Research: Fundamental and applied studies in physiology, pathology, pharmacology, biochemistry, and cell biology that expand knowledge of biological systems and support medical innovation.
Genomics, Proteomics & Precision Medicine: Studies involving genomic sequencing, proteomic analysis, multi-omics integration, biomarker discovery, pharmacogenomics, and personalized healthcare approaches designed to optimize patient-specific treatment strategies.
Translational Medicine & Clinical Research: Research that bridges laboratory discoveries with clinical practice, including translational studies, clinical investigations, novel therapeutic interventions, and evidence-based approaches to disease management.
Regenerative Medicine & Advanced Therapeutics: Investigations into stem cell biology, tissue engineering, gene therapy, cell-based therapies, nanomedicine, and emerging biomedical technologies aimed at restoring or enhancing human health.
Biomedical Informatics & Emerging Technologies: Research exploring bioinformatics, computational biology, artificial intelligence, digital health, systems biology, and data-driven approaches that enhance biomedical discovery, diagnosis, and therapeutic development.
